Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes

Acta Diabetologica

Volumn 46, Issue 3, 2009, Pages 239-242

  Ikeda, Yukio ^a   Inoue, Mari ^a   Suehiro, Tadashi ^a   Arii, Kaoru ^a   Kumon, Yoshitaka ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; PON1; Serum paraoxonase; Type 2 diabetes

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; PON1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ENZYMOLOGY; FORECASTING; JAPAN; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMANS; JAPAN; MALE; MIDDLE AGED;

EID: 69849110325     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-008-0066-3     Document Type: Article

References (17)

1. MI Mackness S Arrol C Abbott PN Durrington 1993 Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated praoxonase Atherosclerosis 104 129 135 8141836 10.1016/0021-9150(93) 90183-U 1:CAS:528:DyaK2cXlvFylsbo%3D
2. Y Ikeda T Suehiro M Inoue Y Nakauchi T Morita K Arii H Ito Y Kumon K Hashimoto 1998 Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus Metabolism 47 598 602 9591753 10.1016/S0026-0495(98)90246-3 1:CAS:528: DyaK1cXjtFertb8%3D (Pubitemid 28213122)
3. M Inoue T Suehiro T Nakamura Y Ikeda Y Kumon K Hashimoto 2000 Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes Metabolism 49 1400 1405 11092501 10.1053/meta.2000.17724 1:CAS:528:DC%2BD3cXot1GmsLs%3D (Pubitemid 30826454)
4. B Mackness MI Mackness S Arrol W Turkie K Julier B Abuasha JE Miller AJM Boulton PN Durrington 1998 Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus Atherosclerosis 139 341 349 9712341 10.1016/S0021-9150(98)00095-1 1:CAS:528:DyaK1cXkt1yitbY%3D (Pubitemid 28361819)
5. M Boemi I Leviev C Sirolla C Pieri M Marra RW James 2001 Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation Atherosclerosis 155 229 235 11223446 10.1016/S0021-9150(00)00556-6 1:CAS:528:DC%2BD3MXht1Oqs7k%3D (Pubitemid 32167144)
6. MR Lakshman CS Gottipati SJ Narasimhan J Munoz P Marmillot ES Nylen 2006 Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus Metabolism 55 1201 1206 16919539 10.1016/j.metabol.2006.06.001 1:CAS:528:DC%2BD28XotlCitr0%3D (Pubitemid 44215939)
7. J McElveen MI Mackness CM Colley T Peard S Warner CH Walker 1986 Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction Clin Chem 32 671 673 3006944 1:STN:280: DyaL287mt1Witg%3D%3D
8. A Ayub MI Mackness S Arrol B Mackness J Patel PN Durrington 1999 Serum paraoxonase after myocardial infarction Arterioscler Thromb Vasc Biol 19 330 335 9974415 1:STN:280:DyaK1M7ktFaqtA%3D%3D
9. NS Kim K Kang MH Cha B-J Kang J Moon BK Kang B-C Yu Y-S Kim SM Choi O-S Bang 2007 Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans Biochem Biophys Res Commun 364 157 162 17936248 10.1016/j.bbrc.2007. 09.119 1:CAS:528:DC%2BD2sXht1aktbrE (Pubitemid 47599458)
10. B Can Demirdögen A Türkanoglu S Bek Y Sanisoglu S Demirkaya O Vural E ArInc O AdalI 2008 Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke Clin Biochem 41 1 9 17920578 10.1016/j.clinbiochem.2007.08.010 (Pubitemid 350216823)
11. T Bhattacharyya SJ Nicholls EJ Topol R Zhang X Yang D Schmitt X Fu M Shao DM Brennan SG Ellis M-L Brennan H Allayee AJ Lusis SL Hazen 2008 Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk JAMA 299 1265 1276 18349088 10.1001/jama.299.11.1265 1:CAS:528:DC%2BD1cXjsVOmtb8%3D
12. PN Durrington B Mackness MI Mackness 2001 Paraoxonase and atherosclerosis Arterioscler Thromb Vasc Biol 21 473 480 11304460 1:CAS:528: DC%2BD3MXivFequ7s%3D
13. JG Wheeler BD Keavney H Watkins R Collins J Danesh 2004 Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies Lancet 363 689 695 15001326 10.1016/S0140-6736(04) 15642-0 1:CAS:528:DC%2BD2cXhs12jur8%3D (Pubitemid 38296555)
14. B Mackness MI Mackness S Arrol W Turkie PN Durrington 1998 Effect of the human serum paraoxoanse 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification FEBS Lett 423 57 60 9506841 10.1016/S0014-5793(98)00064-7 1:CAS:528: DyaK1cXhtVWgtrw%3D (Pubitemid 28098579)
15. J Kotur-Stevuljevic S Spasic Z Jelic-Ivanovic V Spasojevic-Kalimanovska A Stefanovic L Memon D Kalimanovska-Ostric 2008 PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients Clin Biochem 41 1067 1073 18634772 10.1016/j.clinbiochem.2008.06.009 1:CAS:528:DC%2BD1cXhtVent7%2FE
16. KS Robertson E Hawe GJ Miller PJ Talmud SE Humphries 2003 Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II Biochim Biophys Acta 1639 203 212 14636952 1:CAS:528:DC%2BD3sXptVSht70%3D
17. S Turban F Fuentes L Ferlic R Brugada AM Gotto CM Ballantyne AJ Marian 2001 A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin Atherosclerosis 154 633 640 11257264 10.1016/S0021-9150(00)00495-0 1:CAS:528:DC%2BD3MXitVOnu7Y%3D (Pubitemid 32232160)